Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain LGND message board posts where the ticker symbol LGND has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest LGND SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000886163-18-000135 Size: 9 KB
2018-09-18
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001104659-18-055509 Size: 14 KB
2018-09-06
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000886163-18-000133 Size: 12 KB
2018-09-05
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000886163-18-000132 Size: 20 KB
2018-09-05
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000886163-18-000131 Size: 8 KB
2018-09-05
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000886163-18-000127 Size: 4 KB
2018-08-31
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000886163-18-000125 Size: 8 KB
2018-08-29
CT ORDER  Documents Confidential treatment order
Acc-no: 9999999997-18-007445 (34 Act)  Size: 14 KB
2018-08-24 001-33093
181036398
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000886163-18-000123 Size: 7 KB
2018-08-17
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0000886163-18-000122 Size: 6 KB
2018-08-17
More LGND SEC Filings


Related news from
Fri, 21 Sep 2018
22:12:10 +0000
FDA Confirms Positive Safety Profile of Acadia's Nuplazid
Acadia's shares soar more than 20% as the FDA issues a statement reaffirming the positive benefit-risk profile of Nuplazid for patients with Parkinson's disease psychosis.
Fri, 21 Sep 2018
19:39:01 +0000
Does Ligand Pharmaceuticals Incorporated’s (NASDAQ:LGND) Debt Level Pose A Problem?
Small and large cap stocks are widely popular for a variety of reasons, however, mid-cap companies such as Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), with a market cap of US$5.58b, often getRead More...
Fri, 21 Sep 2018
13:30:01 +0000
Is Ligand Pharmaceuticals (LGND) Stock Outpacing Its Medical Peers This Year?
Is (LGND) Outperforming Other Medical Stocks This Year?
Thu, 20 Sep 2018
19:49:07 +0000
Ultragenyx's Shares Surge More Than 80% in the Year So Far
Ultragenyx's (RARE) share price has increased by about 85.2% year to date based on some positive developments for the product candidates of the company.
Thu, 20 Sep 2018
19:12:03 +0000
The 7 Best Biotech Stocks for Investors Who Hate Risk
Most of the buy-and-hold crowd tends to steer clear of biotech stocks, and for good reason. Biotechnology companies can be uncomfortably risky. Far too many horror stories of failed drug trials or the expiration of a crucial patent leading to massive stock plunges have circulated for years now, souring would-be buyers on the entire industry. However, conclusions based on a handful of biotech stocks may have erroneously prevented investors from plugging into a perfectly reasonable risk-reward relationship. Said differently: Not all biotech stocks turn into disasters. The industry as a group is up nearly 70% for the past five years, proving many of these companies can reward patient shareholders who choose wisely. It's simply a matter of doing your homework and having a little common sense. Here are seven biotech stocks that aren't nearly as risky as their typical peer. Thus, they may have a place in more risk-averse portfolios than most investors might presume. SEE ALSO: The 25 Best Stocks to Buy (According to Hedge Funds)
Thu, 20 Sep 2018
14:43:02 +0000
Progenics Pharma's Stock Down on Dismal Phase III Study Data
Progenics Pharmaceuticals' (PGNX) shares down on disappointing results from phase III study evaluating imaging agent, 1404, for prostate cancer detection.
Thu, 20 Sep 2018
12:04:55 +0000
See what the IHS Markit Score report has to say about Ligand Pharmaceuticals Inc.
Ligand Pharmaceuticals Inc NASDAQ NMS:LGND
Wed, 19 Sep 2018
10:54:10 +0000
Zacks.com highlights: Attunity, Helix Energy Solutions Group, Ligand Pharmaceuticals, Turtle Beach and SVB Financial Group
Zacks.com highlights: Attunity, Helix Energy Solutions Group, Ligand Pharmaceuticals, Turtle Beach and SVB Financial Group
Tue, 18 Sep 2018
14:20:52 +0000
Stocks Rally Amid U.S-China Tariff Exchange; FedEx Skids On EPS
The stock market was modestly higher amid an exchange of tariffs between the U.S. and China. FedEx fell after its EPS report.
Tue, 18 Sep 2018
13:03:01 +0000
Enhance Your Gains With These 5 Best Profitable Stocks
The best accounting tool to understand a company's profitability position is ratio analysis.
Tue, 18 Sep 2018
12:50:12 +0000
Cytori's Chemotherapy Candidate Gets Orphan Drug Status
Cytori Therapeutics' (CYTX) chemotherapy candidate, ATI-1123, gets orphan drug status from the FDA for small cell lung cancer.
Thu, 13 Sep 2018
15:42:32 +0000
The Crisis Was in the System
Founder stories are much more interesting than product specs, and this profile is legitimately interesting, but what does it matter that we understand Zuck when Zuck himself so clearly doesn’t even understand Facebook. “Zuck himself so clearly doesn’t even understand Facebook” strikes me as a completely fair and not even controversial position. Mark Zuckerberg built an online facebook for Harvard students.
Wed, 12 Sep 2018
20:23:00 +0000
SEC says short seller spread untrue claims about Ligand Pharamceuticals
The Securities and Exchange Commission charged Gregory Lemelson and Massachusetts-based Lemelson Capital Management LLC with fraud for allegedly illegally profiting from a scheme to drive down the price of San Diego-based Ligand Pharmaceuticals Inc., by taking a short position on behalf of The Amvona Fund, a hedge fund he advised and partly owned and then issuing false information about Ligand. The SEC alleges Lemelson used written reports, interviews, and social media to spread untrue claims, including that Ligand was "teetering on the brink of bankruptcy" and that Ligand's investor relations firm agreed with his view that its flagship Hepatitis C drug, Promacta, was going to become obsolete. Lemelson also allegedly misled investors by citing a European doctor's negative views on the same Ligand drug without revealing the doctor was Amvona's largest investor and had a significant financial interest in seeing Ligand's stock price decline. According to the SEC's complaint, Ligand's stock lost more than one-third of its value during the course of Lemelson's alleged scheme. Short-sellers profit when the price of stock declines. Lemelson collected more than $1.3 million in trading profits for the adviser and the hedge fund. The complaint names the Amvona Fund as a relief defendant and seeks to have it return gains it obtained as a result of Lemelson and his firm's alleged misconduct.
Wed, 12 Sep 2018
20:13:00 +0000
Fr. Emmanuel Lemelson Responds to SEC Charges
MARLBOROUGH, Mass. , Sept. 12, 2018 /PRNewswire/ -- Rev. Fr. Emmanuel Lemelson , the Chief Investment Officer of Lemelson Capital Management, today responded to a civil complaint filed by the United States ...
Tue, 11 Sep 2018
15:37:03 +0000
Endocyte Announces FDA's Acceptance of Trial Endpoint Change
177Lu-PSMA-617, a prostate specific membrane antigen-targeted radioligand therapy, is Endocyte's (ECYT) lead program. It is being evaluated in a phase III study for mCRPC for PSMA-positive patients
Fri, 07 Sep 2018
14:52:02 +0000
Looking for a Top Momentum Pick? Why Ligand Pharmaceuticals (LGND) is a Great Choice
Does Ligand Pharmaceuticals (LGND) have what it takes to be a top stock pick for momentum investors? Let's find out.
Fri, 07 Sep 2018
14:10:02 +0000
Top Ranked Momentum Stocks to Buy for September 7th
Top Ranked Momentum Stocks to Buy for September 7th
Fri, 07 Sep 2018
12:18:00 +0000
3 Top Biotech Stocks to Buy in September
These three relatively small biotechs could be just the ticket.
Wed, 05 Sep 2018
21:15:28 +0000
Looking For Growth? Take A Look At These Biotechnology Stocks
The best biotech companies to invest in tend to have a commonality: A strong streak of earnings growth.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "No friend, no book, no broker, no advisor, no expert has ever provided a tenth what I am able to find here. The best money I have EVER spent, is for membership." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards